According to the final model obtained after employing the backward selection procedure, the odds of ADAM9-positive expression were 7.39 times more likely in patients with squamous cell carcinomas versus those patients with adenocarcinomas (95% CI 1.42, 38.51; p = 0.017). This evidence concerns the gene ADAM9 and squamous cell carcinoma.